2-[{1-(tert-Butyl)-5-(4-piperidin-1-yl-phenyl)-1H-pyrazol-3-yl}methyl]-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide

ID: ALA4069336

PubChem CID: 137634068

Max Phase: Preclinical

Molecular Formula: C26H32N4O2S

Molecular Weight: 464.64

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)(C)n1nc(CN2Cc3ccccc3S2(=O)=O)cc1-c1ccc(C2CCNCC2)cc1

Standard InChI:  InChI=1S/C26H32N4O2S/c1-26(2,3)30-24(21-10-8-19(9-11-21)20-12-14-27-15-13-20)16-23(28-30)18-29-17-22-6-4-5-7-25(22)33(29,31)32/h4-11,16,20,27H,12-15,17-18H2,1-3H3

Standard InChI Key:  AOPHJLXVCLRNSP-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   14.6145   -9.0964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7973   -9.0964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2059   -9.8041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6281   -5.6955    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   12.1070   -6.3585    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.6215   -7.0137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8463   -6.7569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8530   -5.9397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1472   -5.5295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4348   -5.9323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4323   -6.7495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1380   -7.1638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9241   -6.3610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8052   -8.2841    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.1440   -7.7985    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.4001   -7.0266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2186   -7.0266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4665   -7.8045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1819   -8.1976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8798   -7.7757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6002   -8.1691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6144   -8.9838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9162   -9.4098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2000   -9.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3405   -5.2885    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.2998   -4.9455    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.0907   -9.5035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3302   -9.3770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3453  -10.1950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0573  -10.5888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7588  -10.1689    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.7437   -9.3509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0271   -8.9528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  4  8  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
  7 12  2  0
  8  9  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 14 18  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 19 24  2  0
 18 19  1  0
 14  2  1  0
 13 16  1  0
  5 13  1  0
  4 25  2  0
  4 26  2  0
  2 27  1  0
 28 29  1  0
 28 33  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 22 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4069336

    ---

Associated Targets(Human)

CACNA1H Tclin Voltage-gated T-type calcium channel alpha-1H subunit (1913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (3974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 464.64Molecular Weight (Monoisotopic): 464.2246AlogP: 4.48#Rotatable Bonds: 4
Polar Surface Area: 67.23Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.92CX Basic pKa: 10.06CX LogP: 3.64CX LogD: 1.18
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.62Np Likeness Score: -0.74

References

1. Hong JR, Choi YJ, Keum G, Nam G..  (2017)  Synthesis and diabetic neuropathic pain-alleviating effects of 2N-(pyrazol-3-yl)methylbenzo[d]isothiazole-1,1-dioxide derivatives.,  25  (17): [PMID:28720324] [10.1016/j.bmc.2017.07.008]

Source